ARDX
Ardelyx, Inc.$3.03+0.00 (+0.00%)Prev Close$3.03·MCap$747.6M·P/E—·Vol1.95M·Yield—
▲
Buys (12M)
2
$3.89M
▼
Sells (12M)
47
$5.16M
◆
Net Activity
Net Seller
$1.27M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Ardelyx, Inc. (ARDX) has been mixed between buying and selling, with 2 insider purchases totaling $3.89M and 47 insider sales totaling $5.16M. The most recent insider transaction was by Hohenleitner Susan (officer: Chief Financial Officer), who sold $6.0K worth of shares on Aug 25, 2026. Ardelyx, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $747.6M.
ARDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 1,558 | $3.86 | $6.0K | 227,520 |
| Aug 25, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 8,562 | $3.86 | $33.0K | 415,374 |
| Aug 25, 2026 | Bishop John E | officer: See Remarks | Sell | 19,750 | $3.86 | $76.2K | 319,564 |
| Aug 25, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 10,739 | $3.86 | $41.4K | 374,709 |
| Aug 25, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 15,136 | $3.86 | $58.4K | 259,090 |
| Aug 25, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 3,982 | $3.86 | $15.4K | 146,964 |
| Aug 25, 2026 | Kelliher Mike | officer: Chief Business Officer | Sell | 7,758 | $3.86 | $29.9K | 354,314 |
| Aug 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 58,574 | $3.86 | $225.9K | 1,663,357 |
| Jul 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $5.06 | $210.9K | 1,678,366 |
| Jun 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 81,898 | $5.99 | $490.5K | 378,195 |
| Jun 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.67 | $236.3K | 1,699,200 |
| May 22, 2026 | Bishop John E | officer: See Remarks | Sell | 2,306 | $6.27 | $14.5K | 336,845 |
| May 22, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 1,846 | $6.27 | $11.6K | 261,066 |
| May 22, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 1,455 | $6.27 | $9.1K | 229,078 |
| May 22, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 54,748 | $6.27 | $343.1K | 1,759,848 |
| May 22, 2026 | Kelliher Mike | officer: Chief Business Officer | Sell | 7,248 | $6.27 | $45.4K | 361,766 |
| May 22, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 7,998 | $6.27 | $50.1K | 422,804 |
| May 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 6,989 | $6.27 | $43.8K | 434,579 |
| May 22, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 3,719 | $6.27 | $23.3K | 149,836 |
| May 19, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.28 | $261.6K | 1,774,781 |
| Apr 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $6.29 | $262.0K | 1,795,614 |
| Mar 18, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.84 | $243.3K | 1,816,448 |
| Feb 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.25 | $260.6K | 1,836,153 |
| Feb 23, 2026 | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026 | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 23, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,567 |
| Feb 23, 2026 | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,918 |
| Feb 23, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026 | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 20, 2026 | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Feb 20, 2026 | Reilly Joseph James | See Remarks | Sell | 4,989 | $5.85 | $29.2K | 0 |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026 | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Feb 20, 2026 | RAAB MICHAEL | President & CEO | Sell | 45,979 | $5.85 | $268.8K | 0 |
| Feb 20, 2026 | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026 | Bishop John E | See Remarks | Sell | 3,178 | $5.85 | $18.6K | 0 |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Jan 9, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025 | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025 | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
Showing 1–50 of 248
1 / 5
ARDX Insider Buying Activity
The following table shows recent insider purchases of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,918 |
| Feb 20, 2026 | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
ARDX Insider Selling Activity
The following table shows recent insider sales of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 1,558 | $3.86 | $6.0K | 227,520 |
| Aug 25, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 8,562 | $3.86 | $33.0K | 415,374 |
| Aug 25, 2026 | Bishop John E | officer: See Remarks | Sell | 19,750 | $3.86 | $76.2K | 319,564 |
| Aug 25, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 10,739 | $3.86 | $41.4K | 374,709 |
| Aug 25, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 15,136 | $3.86 | $58.4K | 259,090 |
| Aug 25, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 3,982 | $3.86 | $15.4K | 146,964 |
| Aug 25, 2026 | Kelliher Mike | officer: Chief Business Officer | Sell | 7,758 | $3.86 | $29.9K | 354,314 |
| Aug 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 58,574 | $3.86 | $225.9K | 1,663,357 |
| Jul 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $5.06 | $210.9K | 1,678,366 |
| Jun 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 81,898 | $5.99 | $490.5K | 378,195 |
| Jun 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.67 | $236.3K | 1,699,200 |
| May 22, 2026 | Bishop John E | officer: See Remarks | Sell | 2,306 | $6.27 | $14.5K | 336,845 |
| May 22, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 1,846 | $6.27 | $11.6K | 261,066 |
| May 22, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 1,455 | $6.27 | $9.1K | 229,078 |
| May 22, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 54,748 | $6.27 | $343.1K | 1,759,848 |
| May 22, 2026 | Kelliher Mike | officer: Chief Business Officer | Sell | 7,248 | $6.27 | $45.4K | 361,766 |
| May 22, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 7,998 | $6.27 | $50.1K | 422,804 |
| May 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 6,989 | $6.27 | $43.8K | 434,579 |
| May 22, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 3,719 | $6.27 | $23.3K | 149,836 |
| May 19, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.28 | $261.6K | 1,774,781 |
| Apr 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $6.29 | $262.0K | 1,795,614 |
| Mar 18, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.84 | $243.3K | 1,816,448 |
| Feb 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.25 | $260.6K | 1,836,153 |
| Feb 23, 2026 | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026 | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 23, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,567 |
| Feb 23, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026 | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 20, 2026 | Reilly Joseph James | See Remarks | Sell | 4,989 | $5.85 | $29.2K | 0 |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026 | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Feb 20, 2026 | RAAB MICHAEL | President & CEO | Sell | 45,979 | $5.85 | $268.8K | 0 |
| Feb 20, 2026 | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026 | Bishop John E | See Remarks | Sell | 3,178 | $5.85 | $18.6K | 0 |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Jan 9, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025 | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025 | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
ARDX Insiders
Similar Stocks to ARDX
MRNA
Moderna, Inc.
$227.10+2.43%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$963.34+3.82%
$83.15B
RVMD
Revolution Medicines, Inc.
$189.18-1.12%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$160.28-2.86%
$30.46B
UTHR
United Therapeutics Corporation
$596.63-0.35%
$25.15B
INCY
Incyte Corporation
$119.33-0.88%
$23.69B
INSM
Insmed Incorporated
$110.27-2.06%
$21.18B
EXEL
Exelixis, Inc.
$71.30+2.67%
$16.64B